Conjugated bisphenol S metabolites in human serum and whole blood

被引:0
作者
Fu Z. [1 ]
Jin H. [2 ]
Mao W. [1 ]
Hu Z. [1 ]
机构
[1] Department of Pharmacy, Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Zhejiang, Quzhou
[2] Key Laboratory of Microbial Technology for Industrial Pollution Control of Zhejiang Province, College of Environment, Zhejiang University of Technology, Zhejiang, Hangzhou
基金
中国国家自然科学基金;
关键词
BPS-G; BPS-S; Distribution; Serum; Whole blood;
D O I
10.1016/j.chemosphere.2024.142082
中图分类号
学科分类号
摘要
Studies have shown that bisphenol S (BPS) is mainly present as its conjugated metabolites in human blood. However, the distribution of conjugated BPS metabolites in different human blood matrices has not been characterized. In this study, paired human serum and whole blood samples (n = 79) were collected from Chinese participants, and were measured for the occurrence of BPS and 4 BPS metabolites. BPS was detectable in 49% of human serum (<LOD–1.7 ng/mL) and 78% of whole blood (<LOD–2.1 ng/mL) samples. In both human serum and whole blood, BPS-sulfate (BPS–S; 74% and 86%, respectively) and BPS-glucuronide (BPS-G; 68% and 84%, respectively) had higher detection frequency than BPS. Consistently, BPS-S was the predominant BPS metabolite in human serum (mean 0.39 ng/mL) and whole blood (0.41 ng/mL), significantly higher than BPS-G (mean 0.13 and 0.13 ng/mL, respectively). This is contrary to the data from controlled oral exposure studies on model animals and humans, in which BPS-G was the dominant BPS metabolite in serum. BPS-S (mean ± SD, 0.99 ± 0.35) had the highest partitioning coefficient between human serum and whole blood, followed by BPS-G (0.89 ± 0.27) and BPS (0.81 ± 0.28), suggesting their preferential accumulation in the red blood cell fraction. These results represent the first human data on conjugated BPS metabolites in paired human serum and whole blood, which help to elucidate of the occurrence of conjugated BPS metabolites in humans. © 2024 Elsevier Ltd
引用
收藏
相关论文
共 55 条
  • [1] Ahsan N., Ullah H., Ullah W., Jahan S., Comparative effects of Bisphenol S and Bisphenol A on the development of female reproductive system in rats
  • [2] a neonatal exposure study, Chemosphere, 197, pp. 336-343, (2018)
  • [3] Berezhkovskiy L.M., Zhang X.L., Cheong J., A Convenient method to measure blood-plasma concentration ratio using routine plasma collection in in vivo pharmacokinetic studies, J. Pharmaceut. Sci., 100, 12, pp. 5293-5298, (2011)
  • [4] Catenza C.J., Farooq A., Shubear N.S., Donkor K.K., A targeted review on fate, occurrence, risk and health implications of bisphenol analogues, Chemosphere, 268, (2021)
  • [5] Deceuninck Y., Bichon E., Geny T., Veyrand B., Grandin F., Viguie C., Marchand P., Le Bizec B., Quantitative method for conjugated metabolites of bisphenol A and bisphenol S determination in food of animal origin by ultra high performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. A, 1601, pp. 232-242, (2019)
  • [6] Gao C., He H., Qiu W., Zheng Y., Chen Y., Hu S., Zhao X., Oxidative stress, endocrine disturbance, and immune interference in humans showed relationships to serum bisphenol concentrations in a dense industrial area, Environ. Sci. Technol., 55, 3, pp. 1953-1963, (2021)
  • [7] Gayrard V., Lacroix M.Z., Grandin F.C., Collet S.H., Mila H., Viguie C., Gely C.A., Rabozzi B., Bouchard M., Leandri R., Toutain P.L., Picard-Hagen N., Oral systemic bioavailability of bisphenol A and bisphenol S in pigs, Environ. Health Perspect., 127, 7, (2019)
  • [8] Gely C.A., Huesca A., Picard-Hagen N., Toutain P.L., Berrebi A., Gauderat G., Gayrard V., Lacroix M.Z., A new LC/MS method for specific determination of human systemic exposure to bisphenol A, F and S through their metabolites: application to cord blood samples, Environ. Int., 151, (2021)
  • [9] Guo C., Ren F., Jin J., Zhang H., Wang L., Zhang H., Chen J., Internal exposure of Chinese children from a typical coastal city to bisphenols and possible association with thyroid hormone levels, Environ. Int., 156, (2021)
  • [10] Helies-Toussaint C., Peyre L., Costanzo C., Chagnon M.C., Rahmani R., Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study, Toxicol. Appl. Pharmacol., 280, 2, pp. 224-235, (2014)